Efficacy and Safety of Xue-Fu-Zhu-Yu Decoction for Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis
This article is part of Special Issue:
Shuo Zhang,
Zhen-Lin Chen,
Yu-Ping Tang,
Jin-Long Duan,
Kui-Wu Yao,
Shuo Zhang
School of Clinical Medicine (Guang’anmen Hospital), Beijing University of Chinese Medicine, Beijing, China bucm.edu.cn
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China cacms.ac.cn
Search for more papers by this authorZhen-Lin Chen
International Programs Office, Shaanxi University of Chinese Medicine, Xi’an, Shaanxi, China sntcm.edu.cn
Search for more papers by this authorCorresponding Author
Yu-Ping Tang
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi’an, Shaanxi, China sntcm.edu.cn
Search for more papers by this authorJin-Long Duan
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China cacms.ac.cn
Search for more papers by this authorKui-Wu Yao
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China cacms.ac.cn
Search for more papers by this authorShuo Zhang,
Zhen-Lin Chen,
Yu-Ping Tang,
Jin-Long Duan,
Kui-Wu Yao,
Shuo Zhang
School of Clinical Medicine (Guang’anmen Hospital), Beijing University of Chinese Medicine, Beijing, China bucm.edu.cn
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China cacms.ac.cn
Search for more papers by this authorZhen-Lin Chen
International Programs Office, Shaanxi University of Chinese Medicine, Xi’an, Shaanxi, China sntcm.edu.cn
Search for more papers by this authorCorresponding Author
Yu-Ping Tang
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi’an, Shaanxi, China sntcm.edu.cn
Search for more papers by this authorJin-Long Duan
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China cacms.ac.cn
Search for more papers by this authorKui-Wu Yao
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China cacms.ac.cn
Search for more papers by this authorAcademic Editor: Jun-Yong Choi
Abstract
Objective. To systematically evaluate the efficacy and safety of XFZYD for coronary heart disease (CHD). Methods. A comprehensive literature search of randomized controlled trials using XFZYD for CHD was conducted in 10 electronic databases from their establishment to December 20, 2020. The researchers screened the relevant trials in NoteExpress, extracted the data in duplicate independently, assessed the risk of bias in the trials using the Cochrane collaboration tool, and then used Rev Man 5.3 for data analysis. Results. 30 trials with 3126 participants were included for meta-analysis. The results showed that the clinical effects of XFZYD and its combination with chemical drugs (CD) were 1.13 (RR; 1.13; 95% CI, 1.03 to 1.24) and 1.26 (RR; 1.26; 95% CI, 1.20 to 1.32) times those of CD, respectively. And, it could also improve electrocardiogram effect, which was 1.63 (RR; 1.63; 95% CI, 1.04 to 2.53) times that of CD. XFZYD could not only decrease duration of angina pectoris and improve vascular endothelial function but also obviously reduce the TCM syndrome score. When used in combination with CD, it could also lower AF, correct the dyslipidemia, and reduce the blood viscosity. Conclusion. These results demonstrated that XFZYD had great advantages in treating CHD with no obvious adverse reactions. Therefore, it is believed that XFZYD is more suitable for CHD patients with clinical indicators of dyslipidemia, high blood viscosity, or vascular endothelial dysfunction. This study is the first systematic review and meta-analysis with some unique ways, including its comprehensiveness, large-scale search, the novelty of findings, and transparent approach.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Open Research
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
References
- 1 Mayu H., Satoko S., Takanori H. et al., Small dense low-density lipoprotein cholesterol and the risk of coronary heart disease in a Japanese community, Journal of Atherosclerosis and Thrombosis. (2020) 27, no. 7, 669–682.
- 2 Khandaker G. M., Zuber V., Rees J. M. B. et al., Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort, Molecular Psychiatry. (2020) 25, no. 7, 1477–1486, https://doi.org/10.1038/s41380-019-0395-3.
- 3 Chen G., He H. Q., Hu K. et al., Sensitive biomarker analysis of Xue-Fu-Zhu-Yu capsule for patients with qi stagnation and blood stasis pattern: a nested case-control study, Evidence-Based Complementary and Alternative Medicine. (2019) 2019, 7182865, https://doi.org/10.1155/2019/7182865.
- 4 Zhao J. J., Liu H. H., Xu B. Y. et al., The role of Xuefu Zhuyu decoction in prevention of contrast-induced nephropathy after percutaneous coronary intervention, Evidence-Based Complementary and Alternative Medicine. (2020) 2020, 5419016, https://doi.org/10.1155/2020/5419016.
- 5 Wang D., Wang P., Zhang R. et al., Efficacy and safety of Xuefu Zhuyu decoction combined with Western medicine for angina pectoris in coronary heart disease: a protocol for systematic review and meta-analysis, Medicine (Baltimore). (2020) 99, no. 50, e23195, https://doi.org/10.1097/md.0000000000023195.
- 6 Yang T., Li X., Lu Z. et al., Effectiveness and safety of Xuefu Zhuyu decoction for treating coronary heart disease angina: a systematic review and meta-analysis, Medicine. (2019) 98, no. 9, e14708, https://doi.org/10.1097/MD.0000000000014708, 2-s2.0-85062411098.
- 7 Yang X., Xiong X., Yang G., and Wang J., Chinese patent medicine Xuefu Zhuyu capsule for the treatment of unstable angina pectoris: a systematic review of randomized controlled trials, Complementary Therapies in Medicine. (2014) 22, no. 2, 391–399, https://doi.org/10.1016/j.ctim.2014.01.003, 2-s2.0-84898811379.
- 8 Moher D., Liberati A., Tetzlaff J. et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Medicine. (2009) 6, no. 7, e1000097, https://doi.org/10.1371/journal.pmed.1000097, 2-s2.0-68049122102.
- 9 Higgins J. P. T. and Green S., Cochrane Reviewers’ Handbook 5.3.0, 2014, Cochrane, London, UK, http://www.cochranehandbook.org.
- 10
Sedgwick P. and
Marston L., How to read a funnel plot in a meta-analysis, BMJ. (2015) 16, h4718, https://doi.org/10.1136/bmj.h4718, 2-s2.0-84945951888.
10.1136/bmj.h4718 Google Scholar
- 11 Gao B., An R., and Sun Y., Evaluation of the effects on inflammatory factors, angiogenesis and endothelial function in patients with CHD by using Xuefu Zhuyu capsule, World Journal of Traditional Chinese Medicine. (2020) 15, no. 7, 1055–1058.
- 12 Zhang J., The curative effect of Xuefu Zhuyu decoction combined with western medicine on angina pectoris of coronary heart disease and its effect on hemorheology, China Foreign Medical Research. (2020) 18, no. 1, 20–22.
- 13 Huang H., Clinical observation on 20 cases of hyperlipidemia in coronary heart disease with qi stagnation and blood stasis type treated by Xuefu Zhuyu Jiaonang combined with routine western treatment, Journal of Gansu University of Chinese Medicine. (2019) 36, no. 2, 40–43.
- 14 Kong W. W. and Liu Y. Y., Clinical observation of Xuefu Zhuyu decoction combined with western medicine in treating coronary heart disease with atrial fibrillation and blood stasis syndrome, Guangxi Journal of Traditional Chinese Medicine. (2019) 42, no. 3, 18–20.
- 15 Liang K. and Li Q. F., Effect of decoction for removing blood stasis in the chest on clinical symptoms and platelet activating factor level in patients with coronary heart disease and angina pectoris, Chinese Journal of Public Health. (2019) 18, no. 4, 525–527.
- 16 Xi B. and Li X. I., Clinical observation of Xuefu Zhuyu decoction combined with metoprolol sustained-release tablets in treating senile coronary heart disease and angina, Electronic Journal of Clinical Medicine Lit. (2019) 6, no. 94.
- 17 Zhang H. X., Hou F. Z., and Zhang Q., Clincial study on Xuefu Zhuyu capsules combined with routine western medicine for angina pectoris of heart-bloostasis type, Journal of New Chinese Medicine. (2019) 51, no. 10, 90–93.
- 18 An N., The evaluation on the clinical effect and analysis on the safety of Xuefu Zhuyu decoction in the treatment of stable angina pectoris, Chinese Medicine Modern Distance Education of China. (2018) 16, no. 15, 104–106.
- 19 Zheng Q. C., The effect of Xuefu Zhuyu decoction combined with atorvastatin on patients with stable angina pectoris combined with hyperlipidemia and blood lipids and hemorheology, Strait Pharmaceutical Journal. (2018) 30, no. 8, 210–212.
- 20 Li G. S., Effect of Xuefu Zhuyu decoction on adhesion molecules in patients with unstable angina pectoris, Journal of Traditional Chinese Medical Sciences. (2017) 36, no. 19, 4–5.
- 21 Li L. and Yu S. Q., Clinical observation of Suefu Zhuyu decoction in treating 30 cases of angina pectoris and blood stasis syndrome, Hunan Journal of Traditional Chinese Medical Sciences. (2017) 33, no. 3, 47–48.
- 22 Yang T. Y. and Zhang J., Discussion on the curative effect of Xuefu Zhuyu Decoction on coronary heart disease unstable angina pectoris, World Latest Medicine Information. (2017) 17, no. 57, 168–173.
- 23 Dong J. H., Observation on the influence of integrated traditional Chinese and western medicine on LDL-C and TC in treatment of coronary heart disease, Diet Health. (2016) 3, no. 15.
- 24 Liu D. F., Song M. L., and Cheng S. J., Clinical observation on xuefuzhuyu decoction combined with western medicine in the treatment of angina pectoris of coronary heart disease, Asia-Pacific Traditional Medicine. (2016) 12, no. 22, 148–150.
- 25 Yuan J. Q., Study of Xuefuzhuyu Decoction on Treating Left Ventricular Diastolic Dysfunction of Coronary Heart Disease, 2016, Guangzhou University of Chinese Medicine, Guangzhou, China, 1–37.
- 26 Zhang J.-S., Wang Y.-Z., Hu Y.-Q. et al., Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by xuefu zhuyu capsule containing serum in human microvascular endothelial cell 1, Chinese Journal of Integrative Medicine. (2016) 22, no. 8, 605–610, https://doi.org/10.1007/s11655-016-2470-9, 2-s2.0-84974808360.
- 27 Li C. H., Impact of xuefuzhuyu tang on angina of patients with coronary heart disease after interventional treatment, Chinese Journal of Integrated Traditional and Western Medicine. (2015) 2, no. 16, 91–92.
- 28 Wang L., Application of Xuefu Zhuyu capsule in the treatment of patients with coronary heart disease, Chinese Journal of Modern Drug Application. (2015) 9, no. 11, 172–173.
- 29 Wang H. S., Meng D. Y., and Ge Y. J., Thirty cases of unstable angina due to coronary atherosclerotic heart disease treated with Xuefu Zhuyu decoction, Henan Traditional Chinese Medicine. (2015) 35, no. 8, 1805–1806.
- 30 Wang K., Zhang J., Du Y. D. et al., Clinical observation of Xuefu Zhuyu capsule in treating elderly patients with acute myocardial infarction and restenosis after PCI, Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine. (2015) 15, no. 2, 3–5.
- 31 Yang S. Q., Lv X. M., Yang J. H. et al., Clinical observation of Xuefu Zhuyu decoction in treating angina pectoris of coronary heart disease, Pharmacology and Clinical Chinese Material Medicines. (2015) 31, no. 6, 144–146.
- 32 Chen X. M., Ma L., Cao S. J. et al., Clinical observation of Xuefu Zhuyu capsule on patients with coronary heart disease and angina pectoris in August 2013, Medical Recapitulate. (2014) 20, no. 2, 331–333.
- 33 Liu X., Li Y. T., Gu D. J. et al., Influence Observation of Xue Fu Zhu Yu decoction on coronary heart disease angina pectoris patients blood fat, Chinese Medical Journal. (2014) 29, no. 5, 738–739.
- 34 Wang J., Impact of xuefuzhuyu tang on angina of patients with coronary heart disease after interventional treatment, Cardiovascular Disease Electronic Journal of Integrated Traditional Chinese and Western Medicine. (2014) 2, no. 16, 91–92.
- 35 Zhang C. L. and Wang Y. X., Twenty cases of stable angina pectoris of qi stagnation and blood stasis treated with xuefu zhuyu decoction and western medicine, Journal of Traditional Chinese Medical Researches. (2014) 27, no. 7, 20–21.
- 36 Zhang S. J., Comparative study of the efficacy of different formulations of traditional Chinese medicine in treatment of blood stasis type of unstable angina, China Modern Medical and Clinical. (2012) 19, no. 18, 11–13.
- 37 Li A. J., Clinical observation on 45 cases of coronary heart disease with blood stasis syndrome treated by xuefu zhuyu decoction, China Journal of Traditional Chinese Medicine and Pharmacy. (2012) 17, no. 7, 40–41.
- 38 Liao Z. H. and Liang Y., Clinical observation of xuefu zhuyu oral liquid in treating angina pectoris of coronary heart disease, China Journal of Traditional Chinese Medicine and Pharmacy. (2006) 3, no. 5, 17–18.
- 39 Zhang S. W., Clinical Study on the Treatment of Cardiac Fibrosis of Coronary Heart Disease with Blood Stasis Syndrome by Promoting Blood Circulation, 2006, Guangzhou University of Chinese Medine, Guangzhou, China, 1–37.
- 40 Wang W., Ma X. C., Wang X. F. et al., Clinical observation on treatment of 30 cases of coronary heart disease with angina pectoris by refined xuefu capsule, Journal of Traditional Chinese Medicine. (2000) 41, no. 8, 471–473.
- 41 Shi N., Han X., Yu W., Wang L., and Lu A., Adoption in China of clinical practice guidelines for hypertension using traditional Chinese medical approaches: a literature review based on clinical studies, Journal of Alternative and Complementary Medicine. (2013) 19, no. 1, 1–8, https://doi.org/10.1089/acm.2011.0776, 2-s2.0-84872435575.
- 42 Park W. H., Shin S. S., Le Y. C., and Kim C. H., The inhibitory effects of Silso-San-Gami on atherosclerosis in KHC rabbits, Thrombosis Research. (2004) 113, no. 3-4, 235–241, https://doi.org/10.1016/j.thromres.2004.03.011, 2-s2.0-2442485988.
- 43 Bai X., Wang W. X., Fu R. J. et al., Therapeutic potential of hydroxysafflor yellow A on cardio-cerebrovascular diseases, Frontiers in Pharmacology. (2020) 11, 01265, https://doi.org/10.3389/fphar.2020.01265.
- 44 Zhang L., Du J.-R., Wang J. et al., Z-ligustilide extracted from Radix Angelica Sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats, Yakugaku Zasshi. (2009) 129, no. 7, 855–859, https://doi.org/10.1248/yakushi.129.855, 2-s2.0-67650091140.
- 45 Zhang Y.-h., Zhang Y., Li J., Tong W.-X., and Xu F.-Q., Protective effects of Xiongshao capsule on anti-inflammatory function of high-density lipoprotein in an atherosclerosis rabbit model, Chinese Journal of Integrative Medicine. (2015) 23, no. 5, 357–361, https://doi.org/10.1007/s11655-015-2298-8, 2-s2.0-84944691816.
- 46 Wang Y., Guo G., Yang B.-R. et al., Synergistic effects of Chuanxiong-Chishao herb-pair on promoting angiogenesis at network pharmacological and pharmacodynamic levels, Chinese Journal of Integrative Medicine. (2017) 23, no. 9, 654–662, https://doi.org/10.1007/s11655-017-2408-x, 2-s2.0-85019746079.
- 47 Zhang R., Zhou J., Li M. et al., Ameliorating effect and potential mechanism of rehmannia glutinosa oligosaccharides on the impaired glucose metabolism in chronic stress rats fed with high-fat diet, Phytomedicine. (2014) 21, no. 5, 607–614, https://doi.org/10.1016/j.phymed.2013.11.008, 2-s2.0-84898057840.
- 48 Huang C., Cui Y., Ji L. et al., Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult, Pharmaceutical Biology. (2013) 51, no. 4, 463–473, https://doi.org/10.3109/13880209.2012.740052, 2-s2.0-84875123353.
- 49 Negishi H., Sugahama S., Kawakamia A. et al., Effect of angelica acutiloba extract on blood flow regulation in stroke-prone spontaneously hypertensive rats, Natural product communications. (2016) 11, no. 10, 1497–1498, https://doi.org/10.1177/1934578x1601101018.
- 50 Lin Y. C., Lin Y. C., Kuo W. W. et al., Platycodin D reverses pathological cardiac hypertrophy and fibrosis in spontaneously hypertensive rats, American Journal of Chinese Medicine. (2018) 46, no. 3, 537–549, https://doi.org/10.1142/S0192415X18500271, 2-s2.0-85044483834.
- 51 Kim S.-Y., Kim H.-J., Lee M.-K. et al., Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet, Journal of Medicinal Food. (2006) 9, no. 4, 582–586, https://doi.org/10.1089/jmf.2006.9.582, 2-s2.0-33846196243.
- 52 Jin Y.-R., Han X.-H., Zhang Y.-H. et al., Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-γ2 phosphorylation and cyclooxygenase-1 activity, Atherosclerosis. (2007) 194, no. 1, 144–152, https://doi.org/10.1016/j.atherosclerosis.2006.10.011, 2-s2.0-34648837869.
- 53 Jiang H., Yang L., Hou A. et al., Botany, traditional uses, phytochemistry, analytical methods, processing, pharmacology and pharmacokinetics of Bupleuri radix: a systematic review, Biomedicine and Pharmacotherapy. (2020) 131, 110679, https://doi.org/10.1016/j.biopha.2020.110679.
- 54 Nwe K. H., Hamid A., Morat P. B. et al., Differential regulation of theoxidative 11 beta-hydroxystcroid dchydrogcnasc actively in tcstis and liver, Steroids. (2000) 65, no. 1, 40–45, https://doi.org/10.1016/s0039-128x(99)00078-1, 2-s2.0-0033990250.
- 55 Meng F., Lai H., Luo Z. et al., Effect of Xuefu Zhuyu decoction pretreatment on myocardium in sepsis rats, Evidence-Based Complementary and Alternative Medicine. (2008) 2939307.
- 56 Shi X., Zhu H., Zhang Y., Zhou M., Tang D., and Zhang H., Xuefuzhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy, BMC Complementary and Alternative Medicine. (2017) 17, no. 1, https://doi.org/10.1186/s12906-017-1822-0, 2-s2.0-85021156712.
- 57 Liu J., Zhang J., Huan L., Zhu X., Hu P., and Chen W., XuefuZhuyu tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment, OncoTargets and Therapy. (2016) 9, 3603–3612, https://doi.org/10.2147/ott.s104108, 2-s2.0-84975275550.
- 58 Zhang M. C., Clinical study of Xuefu Zhuyu decoction on unstable angina pectoris of coronary heart disease, Shanxi Journal of Traditional Chinese Medicine. (2016) 32, no. 10, 36–37.
- 59 Xu W. H., Zhao Y., Ning G. L. et al., Analysis of the molecular mechanism of Xuefu Zhuyu decoction in the treatment of coronary heart disease based on bibliometrics and systematic pharmacology, Chinese Traditional Patent Medicine. (2020) 42, no. 11, 3040–3046.
- 60 Dou X. B., Han T. Q., Zhao Y. F. et al., Effects of Xuefuzhuyu decoction on blood fat and myocardial enzymes in the coronary heart disease rat model, Guangdong Medical Journal. (2016) 40, no. 6, 767–771.
- 61 Chen M.-Q., Yao K.-W., Liu Z.-J., Feng X.-X., and Xiao Y., Xuefu Zhuyu oral liquid prevents apoptosis of ischemic myocardium cells in rats by regulating SIRT1 and its pathway-related genes, Chinese Journal of Integrative Medicine. (2020) 26, no. 6, 442–447, https://doi.org/10.1007/s11655-019-3076-9.
- 62 Shi W.-L., Lu P.-F., Gao D., Song J., and Chen K.-J., Effect of Xuefu Zhuyu capsule on angiogenesis in hindlimb ischemic rats, Chinese Journal of Integrative Medicine. (2020) 26, no. 1, 39–45, https://doi.org/10.1007/s11655-019-3059-x, 2-s2.0-85071778078.
